Event simulation and external validation applied in published health economic models for obesity: a systematic review

References

• World Health Organization (WHO) 2003. Fact sheet on obesity Available from: http://www.who.int/dietphysicalactivity/media/en/gsfs_obesity.pdf. Accessed 2017 Jul 24
   Google Scholar
• WHO 2016. Updated fact sheet n 311 on obesity and overweight [cited 2017 Jul 24]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.
   Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–781.
   PubMed Web of Science ®Google Scholar
• WHO 2014. Updated fact sheet N 311 on obesity and overweight. [cited 2017 Jul 24]. Available from: http://www.wpro.who.int/mediacentre/factsheets/obesity/en/.
   Google Scholar
• Tremmel M, Gerdtham UG, Nilsson PM, et al. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health. 2017;14:4.
   Web of Science ®Google Scholar
• Schwander B, Hiligsmann M, Nuijten M, et al. Systematic review and overview of health economic evaluation models in obesity prevention and therapy. Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):561–570.
   PubMed Web of Science ®Google Scholar
• Eddy DM, Hollingworth W, Caro JJ, et al. ISPOR−SMDM modeling good research practices task force. Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force–7. Value Health. 2012;15(6):843–850.
   PubMed Web of Science ®Google Scholar
• Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161(13):1581–1586.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, et al. for the PRISMA Group, 2009. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. BMJ. 2009;339:b2535–b2535.
   PubMed Web of Science ®Google Scholar
• Boyers D, Avenell A, Stewart F, et al. A systematic review of the cost-effectiveness of non-surgical obesity interventions in men. Obes Res Clin Pract. 2015;9(4):310–327.
   PubMed Web of Science ®Google Scholar
• Flego A, Keating C, Moodie M. Cost-effectiveness of whole-of-community obesity prevention programs: an overview of the evidence. Expert Rev Pharmacoecon Outcomes Res. 2014;14(5):719–727.
   PubMed Web of Science ®Google Scholar
• Wang BC, Furnback W. Modelling the long-term outcomes of bariatric surgery: A review of cost-effectiveness studies. Best Pract Res Clin Gastroenterol. 2013;27(6):987–995.
   PubMed Web of Science ®Google Scholar
• Henteleff HJ, Birch DW, Hallowell PT. CAGS/ACS EVIDENCE BASED REVIEws in Surgery Group. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Can J Surg. 2013;56(5):353–355.
   PubMed Web of Science ®Google Scholar
• Griffiths UK, Anigbogu B, Nanchahal K. Economic evaluations of adult weight management interventions: a systematic literature review focusing on methods used for determining health impacts. Appl Health Econ Health Policy. 2012;10(3):145–162.
   PubMedGoogle Scholar
• Gandjour A. Cost-effectiveness of preventing weight gain and obesity: what we know and what we need to know. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):297–305.
   PubMed Web of Science ®Google Scholar
• John J, Wolfenstetter SB, Wenig CM. An economic perspective on childhood obesity: recent findings on cost of illness and cost effectiveness of interventions. Nutrition. 2012;28(9):829–839.
   PubMed Web of Science ®Google Scholar
• Lehnert T, Sonntag D, Konnopka A, et al. The long-term cost-effectiveness of obesity prevention interventions: systematic literature review. Obes Rev. 2012;13(6):537–553.
   PubMed Web of Science ®Google Scholar
• Loveman E, Frampton GK, Shepherd J, et al. The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review. Health Technol Assess. 2011;15(2):1–182.
   Web of Science ®Google Scholar
• Levy DT, Mabry PL, Wang YC, et al. Simulation models of obesity: a review of the literature and implications for research and policy. Obes Rev. 2011;12(5):378–394.
   PubMed Web of Science ®Google Scholar
• Saha S, Gerdtham UG, Johansson P. Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Public Health. 2010;7(8):3150–3195.
   PubMed Web of Science ®Google Scholar
• Neovius M, Narbro K. Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review. Int J Obes (Lond). 2008;32(12):1752–1763.
   PubMed Web of Science ®Google Scholar
• Drummond MF, O’Brien B, Stoddart GL. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1997.
   Google Scholar
• Weinstein MC, O’Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR task force on good research practices-modeling studies. Value Health. 2003;6(1):9–17.
   PubMed Web of Science ®Google Scholar
• D’Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753.
   PubMed Web of Science ®Google Scholar
• D’Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000;139(2 Pt 1):272–281.
   PubMed Web of Science ®Google Scholar
• Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412.
   PubMed Web of Science ®Google Scholar
• Hoerger TJ, Harris R, Hicks KA, et al. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med. 2004;140(9):689–699.
   PubMed Web of Science ®Google Scholar
• Palmer AJ, Roze S, Valentine WJ, et al. The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin. 2004;20(Suppl 1):S5–26.
   PubMed Web of Science ®Google Scholar
• Eddy DM, Schlessinger L. Archimedes: a trial-validated model of diabetes. Diabetes Care. 2003 Nov;26(11):3093–3101.
   PubMed Web of Science ®Google Scholar
• Caro JJ, Ozer Stillman IO, Danel A, et al. Cost effectiveness of rimonabant use in patients at increased cardiometabolic risk: estimates from a Markov model. JME. 2007;10(3):239–254.
   Google Scholar
• Kahn R, Robertson RM, Smith R, et al. The impact of prevention on reducing the burden of cardiovascular disease. Circulation. 2008;118(5):576–585.
   PubMed Web of Science ®Google Scholar
• Ikramuddin S, Klingman D, Swan T, et al. Cost-effectiveness of Roux-en-Y gastric bypass in type 2 diabetes patients. Am J Manag Care. 2009;15(9):607–615.
   PubMed Web of Science ®Google Scholar
• Hoerger TJ, Segel JE, Zhang P, et al. Cost-effectiveness of bariatric surgery for persons with diabetes. Diabetes. 2010;59(suppl.1). Congress of the American Diabetes Association. 70th Scientific Sessions: Abstract Number 201-OR. https://professional.diabetes.org/abstract/cost-effectiveness-bariatric-surgery-obese-persons-diabetes.
   Google Scholar
• Hoerger TJ, Zhang P, Segel JE, et al. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. Diabetes Care. 2010;33(9):1933–1939.
   PubMed Web of Science ®Google Scholar
• Pollock RF, Muduma G, Valentine WJ. Evaluating the cost-effectiveness of laparoscopic adjustable gastric banding versus standard medical management in obese patients with type 2 diabetes in the UK. Diabetes Obes Metab. 2013;15(2):121–129.
   PubMed Web of Science ®Google Scholar
• Castilla I, Mar J, Valcárcel-Nazco C, et al. Cost-utility analysis of gastric bypass for severely obese patients in Spain. Obes Surg. 2014;24(12):2061–2068.
   PubMed Web of Science ®Google Scholar
• Wilson KJ, Brown HS, Bastida E. Cost-effectiveness of a community-based weight control intervention targeting a low-socioeconomic-status Mexican-origin population. Health Promot Pract. 2015;16(1):101–108.
   PubMed Web of Science ®Google Scholar
• Hoerger TJ, Crouse WL, Zhuo X, et al. Medicare’s intensive behavioral therapy for obesity: an exploratory cost-effectiveness analysis. Am J Prev Med. 2015;48(4):419–425.
   PubMed Web of Science ®Google Scholar
• Borisenko O, Adam D, Funch-Jensen P, et al. Bariatric surgery can lead to net cost savings to health care systems: results from a comprehensive European decision analytic model. Obes Surg. 2015;25(9):1559–1568.
   PubMed Web of Science ®Google Scholar
• Hoerger TJ, Segel JE, Zhang P, et al. Validation of the CDC-RTI diabetes cost-effectiveness model. RTI Press publication No. MR-0013-0909. Research Triangle Park, NC: RTI International, RTI Press; 2009. Available from:: http://www.rti.org/rtipress
   Google Scholar
• Palmer AJ, Roze S, Valentine WJ, et al. Validation of the CORE Diabetes Model against epidemiological and clinical studies. Curr Med Res Opin. 2004 Aug;20(Suppl 1):S27–40.
   PubMed Web of Science ®Google Scholar
• Eddy DM, Schlessinger L. Validation of the archimedes diabetes model. Diabetes Care. 2003 Nov;26(11):3102–3110.
   PubMed Web of Science ®Google Scholar
• West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet. 1996 Nov 16;348(9038):1339–1342.
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002 Dec 18;288(23):2981–2997.
   PubMed Web of Science ®Google Scholar
• Deedwania P, Barter P, Carmena R, et al. Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the treating to new targets study. Lancet. 2006 Sep 9;368(9539):919–928.
   PubMed Web of Science ®Google Scholar
• Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004 Aug 21–27;364(9435):685–696.
   PubMed Web of Science ®Google Scholar
• Sacco M, Pellegrini F, Roncaglioni MC, et al. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care. 2003 Dec;26(12):3264–3272.
   PubMed Web of Science ®Google Scholar
• Soriguer F, Goday A, Bosch-Comas A, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the [email protected]. Study Diabetologia. 2012 Jan;55(1):88–93.
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Larson MG, Beiser A, et al. Lifetime risk of developing coronary heart disease. Lancet. 1999 Jan 9;353(9147):89–92.
   PubMed Web of Science ®Google Scholar
• Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol. 2007 Dec;6(12):1106–1114.
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005 Sep 10–16;366(9489):895–906.
   PubMed Web of Science ®Google Scholar
• Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013 Jul 11;369(2):145–154.
   PubMed Web of Science ®Google Scholar
• ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010 Apr 29;362(17):1575–1585.
   PubMed Web of Science ®Google Scholar
• Hedenbro JL, Näslund E, Boman L, et al. Formation of the Scandinavian Obesity Surgery Registry, SOReg. Obes Surg. 2015 Oct;25(10):1893–1900.
   PubMed Web of Science ®Google Scholar
• Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med. 2002;136(8):575–581.
   PubMed Web of Science ®Google Scholar